Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas.
Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts.
Closing share price
|FY, 2013||FY, 2014||FY, 2015||FY, 2016|
|$247.1 m||$288.7 m||$324.2 m||$367 m|
Revenue growth, %
|($45 m)||($51.5 m)||($73.5 m)||($28.9 m)|